Therapy for Rare Bone Disorder Shows Promise in NIH Clinical Trial
April 4, 2023 -- A clinical trial at the National Institutes of Health found that a medication, denosumab, significantly reduced abnormal bone turnover in adults with fibrous dysplasia, a rare disease marked by weak and misshapen bones. Bone...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials
More News: Clinical Trials | National Institutes of Health (NIH) | Pharmaceuticals | Rare Diseases | Xgeva